Eosinophil and T cell markers predict functional decline in COPD patients

Respiratory Research

Volumn 10, Issue , 2009, Pages

  D'Armiento, Jeanine M ^a   Scharf, Steven M ^b   Roth, Michael D ^c   Connett, John E ^d   Ghio, Andrew ^e   Sternberg, David ^a   Goldin, Jonathan G ^c   Louis, Thomas A ^f   Mao, Jenny T ^c   O'Connor, George T ^g   Ramsdell, Joe W ^h   Ries, Andrew L ^h   Schluger, Neil W ^a   Sciurba, Frank C ⁱ   Skeans, Melissa A ^c   Voelker, Helen ^c   Walter, Robert E ^f   Wendt, Christine H ^c   Weinmann, Gail G ^j   Wise, Robert A ^e   Foronjy, Robert F ^a   more..

^a Columbia University ^*  (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

ⁱ UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^j NATIONAL INSTITUTES OF HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CCL11 PROTEIN, HUMAN; CYTOKINE; IL2 PROTEIN, HUMAN; RESPIRATORY TRACT AGENT; RETINOIC ACID;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; BLOOD SAMPLING; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; EOSINOPHIL; FEMALE; HUMAN; LUNG FUNCTION; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SMOKING; T LYMPHOCYTE; BLOOD; BRONCHOSCOPY; DRUG EFFECT; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; IMMUNOLOGY; LUNG; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; RANDOMIZED CONTROLLED TRIAL; TIME; VITAL CAPACITY;

ADULT; AGED; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CHEMOKINE CCL11; CYTOKINES; DISEASE PROGRESSION; EOSINOPHILS; FORCED EXPIRATORY VOLUME; HUMANS; INTERLEUKIN-2; LUNG; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY SYSTEM AGENTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES; TIME FACTORS; TRETINOIN; VITAL CAPACITY;

EID: 73949134312     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-10-113     Document Type: Article

References (45)

1. Perng DW, Huang HY, Chen HM, Lee YC, Perng RP. Characteristics of airway inflammation and bronchodilator reversibility in COPD: a potential guide to treatment. Chest 2004, 126(2):375-381. 10.1378/chest.126.2.375, 15302720.
2. Sullivan AK, Simonian PL, Falta MT, Mitchell JD, Cosgrove GP, Brown KK, Kotzin BL, Voelkel NF, Fontenot AP. Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema. Am J Respir Crit Care Med 2005, 172(5):590-596. 10.1164/rccm.200410-1332OC, 2718531, 15937291.
3. Tzanakis N, Chrysofakis G, Tsoumakidou M, Kyriakou D, Tsiligianni J, Bouros D, Siafakas NM. Induced sputum CD8+ T-lymphocyte subpopulations in chronic obstructive pulmonary disease. Respir Med 2004, 98(1):57-65. 10.1016/j.rmed.2003.08.007, 14959815.
4. Wei S, Kryczek I, Zou W. Regulatory T-cell compartmentalization and trafficking. Blood 2006, 108(2):426-431. 10.1182/blood-2006-01-0177, 1895488, 16537800.
5. Lintomen L, Franchi G, Nowill A, Condino-Neto A, de Nucci G, Zanesco A, Antunes E. Human eosinophil adhesion and degranulation stimulated with eotaxin-1 and RANTES in vitro: lack of interaction with nitric oxide. BMC Pulm Med 2008, 8:13. 10.1186/1471-2466-8-13, 2527293, 18700028.
6. Decramer M, Rutten-van Molken M, Dekhuijzen PN, Troosters T, van Herwaarden C, Pellegrino R, van Schayck CP, Olivieri D, Del Donno M, De Backer W, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet 2005, 365(9470):1552-1560. 10.1016/S0140-6736(05)66456-2, 15866309.
7. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med 2002, 166(5):675-679. 10.1164/rccm.2112096, 12204864.
8. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977, 1(6077):1645-1648. 10.1136/bmj.1.6077.1645, 1607732, 871704.
9. Roth MD, Connett JE, D'Armiento JM, Foronjy RF, Friedman PJ, Goldin JG, Louis TA, Mao JT, Muindi JR, O'Connor GT, et al. Feasibility of retinoids for the treatment of emphysema study. Chest 2006, 130(5):1334-1345. 10.1378/chest.130.5.1334, 17099008.
10. Society AT. Lung Function Testing: Selection of Reference Values From a Sample of the General US Population. Amercan Review of Respiratory Diseases 1991, 1444:1202-1206.
11. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999, 159(1):179-187.
12. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med 1995, 152(5 Pt 2):S77-121.
13. Crapo RO, Morris AH. Standardized single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis 1981, 123(2):185-189.
14. Saetta M, Baraldo S, Corbino L, Turato G, Braccioni F, Rea F, Cavallesco G, Tropeano G, Mapp CE, Maestrelli P, et al. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 160(2):711-717.
15. O'Shaughnessy TC, Ansari TW, Barnes NC, Jeffery PK. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. Am J Respir Crit Care Med 1997, 155(3):852-857.
16. Saetta M, Di Stefano A, Turato G, Facchini FM, Corbino L, Mapp CE, Maestrelli P, Ciaccia A, Fabbri LM. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157(3 Pt 1):822-826.
17. Glader P, von Wachenfeldt K, Lofdahl CG. Systemic CD4+ T-cell activation is correlated with FEV1 in smokers. Respir Med 2006, 100(6):1088-1093. 10.1016/j.rmed.2005.09.025, 16246539.
18. Barcelo B, Pons J, Ferrer JM, Sauleda J, Fuster A, Agusti AG. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking. Eur Respir J 2008, 31(3):555-562. 10.1183/09031936.00010407, 18057064.
19. Doherty PC, Topham DJ, Tripp RA, Cardin RD, Brooks JW, Stevenson PG. Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol Rev 1997, 159:105-117. 10.1111/j.1600-065X.1997.tb01010.x, 9416506.
20. Meshi B, Vitalis TZ, Ionescu D, Elliott WM, Liu C, Wang XD, Hayashi S, Hogg JC. Emphysematous lung destruction by cigarette smoke. The effects of latent adenoviral infection on the lung inflammatory response. Am J Respir Cell Mol Biol 2002, 26(1):52-57.
21. Chakrabarti S, Mautner V, Osman H, Collingham KE, Fegan CD, Klapper PE, Moss PA, Milligan DW. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 2002, 100(5):1619-1627. 10.1182/blood-2002-02-0377, 12176880.
22. Chang J, Braciale TJ. Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract. Nat Med 2002, 8(1):54-60. 10.1038/nm0102-54, 11786907.
23. Chang J, Choi SY, Jin HT, Sung YC, Braciale TJ. Improved effector activity and memory CD8 T cell development by IL-2 expression during experimental respiratory syncytial virus infection. J Immunol 2004, 172(1):503-508.
24. Rohde G, Wiethege A, Borg I, Kauth M, Bauer TT, Gillissen A, Bufe A, Schultze-Werninghaus G. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 2003, 58(1):37-42. 10.1136/thorax.58.1.37, 1746460, 12511718.
25. Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, Maccallum P, Meade TW, Jeffries DJ, Johnston SL, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 164(9):1618-1623.
26. King PT, Ngui J, Farmer MW, Hutchinson P, Holmes PW, Holdsworth SR. Cytotoxic T lymphocyte and natural killer cell responses to non-typeable Haemophilus influenzae. Clin Exp Immunol 2008, 152(3):542-551. 2453218, 18462210.
27. Robbins CS, Franco F, Mouded M, Cernadas M, Shapiro SD. Cigarette smoke exposure impairs dendritic cell maturation and T cell proliferation in thoracic lymph nodes of mice. J Immunol 2008, 180(10):6623-6628.
28. Nelson BH, Willerford DM. Biology of the interleukin-2 receptor. Adv Immunol 1998, 70:1-81. full_text, 9755337.
29. Mor F, Cohen IR. IL-2 rescues antigen-specific T cells from radiation or dexamethasone-induced apoptosis. Correlation with induction of Bcl-2. J Immunol 1996, 156(2):515-522.
30. Mueller DL, Seiffert S, Fang W, Behrens TW. Differential regulation of bcl-2 and bcl-x by CD3, CD28, and the IL-2 receptor in cloned CD4+ helper T cells. A model for the long-term survival of memory cells. J Immunol 1996, 156(5):1764-1771.
31. Hodge S, Hodge G, Holmes M, Reynolds PN. Increased peripheral blood T-cell apoptosis and decreased Bcl-2 in chronic obstructive pulmonary disease. Immunol Cell Biol 2005, 83(2):160-166. 10.1111/j.1440-1711.2005.01317.x, 15748212.
32. Hodge S, Hodge G, Holmes M, Reynolds PN. Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation. Eur Respir J 2005, 25(3):447-454. 10.1183/09031936.05.00077604, 15738287.
33. de Bree GJ, Heidema J, van Leeuwen EM, van Bleek GM, Jonkers RE, Jansen HM, van Lier RA, Out TA. Respiratory syncytial virus-specific CD8+ memory T cell responses in elderly persons. J Infect Dis 2005, 191(10):1710-1718. 10.1086/429695, 15838799.
34. Robbins CS, Dawe DE, Goncharova SI, Pouladi MA, Drannik AG, Swirski FK, Cox G, Stampfli MR. Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness. Am J Respir Cell Mol Biol 2004, 30(2):202-211. 10.1165/rcmb.2003-0259OC, 12920055.
35. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, Fabbri LM, Johnston SL. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006, 173(10):1114-1121. 10.1164/rccm.200506-859OC, 16484677.
36. Vandivier RW, Henson PM, Douglas IS. Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest 2006, 129(6):1673-1682. 10.1378/chest.129.6.1673, 16778289.
37. Hodge S, Hodge G, Scicchitano R, Reynolds PN, Holmes M. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol Cell Biol 2003, 81(4):289-296. 10.1046/j.1440-1711.2003.t01-1-01170.x, 12848850.
38. Van Parijs L, Biuckians A, Ibragimov A, Alt FW, Willerford DM, Abbas AK. Functional responses and apoptosis of CD25 (IL-2R alpha)-deficient T cells expressing a transgenic antigen receptor. J Immunol 1997, 158(8):3738-3745.
39. Van Parijs L, Abbas AK. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 1998, 280(5361):243-248. 10.1126/science.280.5361.243, 9535647.
40. Taraseviciene-Stewart L, Scerbavicius R, Choe KH, Moore M, Sullivan A, Nicolls MR, Fontenot AP, Tuder RM, Voelkel NF. An animal model of autoimmune emphysema. Am J Respir Crit Care Med 2005, 171(7):734-742. 10.1164/rccm.200409-1275OC, 15563631.
41. Ponath PD, Qin S, Post TW, Wang J, Wu L, Gerard NP, Newman W, Gerard C, Mackay CR. Molecular cloning and characterization of a human eotaxin-1 receptor expressed selectively on eosinophils. J Exp Med 1996, 183(6):2437-2448. 10.1084/jem.183.6.2437, 2192612, 8676064.
42. Ponath PD, Qin S, Ringler DJ, Clark-Lewis I, Wang J, Kassam N, Smith H, Shi X, Gonzalo JA, Newman W, et al. Cloning of the human eosinophil chemoattractant, eotaxin-1. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 1996, 97(3):604-612. 10.1172/JCI118456, 507095, 8609214.
43. Bocchino V, Bertorelli G, Bertrand CP, Ponath PD, Newman W, Franco C, Marruchella A, Merlini S, Del Donno M, Zhuo X, et al. Eotaxin-1 and CCR3 are up-regulated in exacerbations of chronic bronchitis. Allergy 2002, 57(1):17-22. 10.1034/j.1398-9995.2002.13230.x, 11991282.
44. Miller M, Ramsdell J, Friedman PJ, Cho JY, Renvall M, Broide DH. Computed tomographic scan-diagnosed chronic obstructive pulmonary disease-emphysema: eotaxin-1 is associated with bronchodilator response and extent of emphysema. J Allergy Clin Immunol 2007, 120(5):1118-1125. 10.1016/j.jaci.2007.08.045, 17983873.
45. Barnes PJ, Chowdhury B, Kharitonov SA, Magnussen H, Page CP, Postma D, Saetta M. Pulmonary biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 174(1):6-14. 10.1164/rccm.200510-1659PP, 16556692.